Spots Global Cancer Trial Database for A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT

Official Title: A Retrospective Analysis to Evaluate Long Term Outcomes of Squamous Cell Carcinoma Patients Previously Treated With Alpha Diffusing Alpha-emitters Radiation Therapy

Study ID: NCT05125354

Conditions

Squamous Cell Carcinoma

DaRT Treated Patients

Interventions

Study Description

Brief Summary: Evaluation of long-term efficacy outcomes of patients previously treated with the Alpha DaRT seeds for management of their malignancy following initial response.

Detailed Description: Medical records of patients that previously underwent the Alpha DaRT treatment will be reviewed by an authorized staff member. Evaluation of long-term outcomes of patients previously treated with the Alpha DaRT seeds for management of their malignancy following initial response. These outcomes include: * Safety - assessment of late onset of Alpha DaRT related AE in patients treated with the Alpha DaRT seeds * Efficacy - * assessment of local recurrence rates in patients who achieved initial complete response (CR) following the Alpha DaRT treatment * assessment of duration of response in patients who achieved initial CR following the Alpha DaRT treatment * assessment of survival status in patients treated with the Alpha DaRT seeds